Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark S Roberts

Showing results (81-90 of 162) with videos related to

Pageof 17
Sort By:
Sexually Transmitted Diseases|November 23, 2007
Quality of life utilities for pelvic inflammatory disease health statesKenneth J Smith, Joel Tsevat, Roberta B Ness, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 20, 2020
Economic analysis of screening for subclinical rejection in kidney transplantation using protocol biopsies and noninvasive biomarkersChethan M Puttarajappa, Rajil B Mehta, Mark S Roberts, et al.
Medical Care|March 26, 2008
What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule?R Scott Braithwaite, David O Meltzer, Joseph T King, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 2016
Cost-Effectiveness Analysis of Stereotactic Body Radiation Therapy Compared With Radiofrequency Ablation for Inoperable Colorectal Liver MetastasesHayeon Kim, Beant Gill, Sushil Beriwal, et al.
Plos One|June 26, 2014
Should expectations about the rate of new antiretroviral drug development impact the timing of HIV treatment initiation and expectations about treatment benefits?Amin Khademi, R Scott Braithwaite, Denis Saure, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|August 30, 2019
Exclusion Criteria as Measurements II: Effects on Utility FunctionsBarry Dewitt, Baruch Fischhoff, Alexander L Davis, et al.
Journal of Clinical Epidemiology|January 26, 2026
An Agent-based Model of the Effects of Limited Vaccination on Novel Respiratory InfectionsMary G Krauland, Alexis J Mandell, Katherine V Williams, et al.
American Journal of Preventive Medicine|March 20, 2022
Impact of Low Rates of Influenza on Next-Season Influenza InfectionsMary G Krauland, David D Galloway, Jonathan M Raviotta, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|August 30, 2019
Exclusion Criteria as Measurements I: Identifying Invalid ResponsesBarry Dewitt, Baruch Fischhoff, Alexander L Davis, et al.
Science (New York, N.Y.)|September 22, 2018
Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016Hawre Jalal, Jeanine M Buchanich, Mark S Roberts, et al.
Pageof 17

Showing results (81-90 of 162) with videos related to

Sort By:
Pageof 17
Sexually Transmitted Diseases|November 23, 2007
Quality of life utilities for pelvic inflammatory disease health statesKenneth J Smith, Joel Tsevat, Roberta B Ness, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 20, 2020
Economic analysis of screening for subclinical rejection in kidney transplantation using protocol biopsies and noninvasive biomarkersChethan M Puttarajappa, Rajil B Mehta, Mark S Roberts, et al.
Medical Care|March 26, 2008
What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule?R Scott Braithwaite, David O Meltzer, Joseph T King, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 2016
Cost-Effectiveness Analysis of Stereotactic Body Radiation Therapy Compared With Radiofrequency Ablation for Inoperable Colorectal Liver MetastasesHayeon Kim, Beant Gill, Sushil Beriwal, et al.
Plos One|June 26, 2014
Should expectations about the rate of new antiretroviral drug development impact the timing of HIV treatment initiation and expectations about treatment benefits?Amin Khademi, R Scott Braithwaite, Denis Saure, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|August 30, 2019
Exclusion Criteria as Measurements II: Effects on Utility FunctionsBarry Dewitt, Baruch Fischhoff, Alexander L Davis, et al.
Journal of Clinical Epidemiology|January 26, 2026
An Agent-based Model of the Effects of Limited Vaccination on Novel Respiratory InfectionsMary G Krauland, Alexis J Mandell, Katherine V Williams, et al.
American Journal of Preventive Medicine|March 20, 2022
Impact of Low Rates of Influenza on Next-Season Influenza InfectionsMary G Krauland, David D Galloway, Jonathan M Raviotta, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|August 30, 2019
Exclusion Criteria as Measurements I: Identifying Invalid ResponsesBarry Dewitt, Baruch Fischhoff, Alexander L Davis, et al.
Science (New York, N.Y.)|September 22, 2018
Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016Hawre Jalal, Jeanine M Buchanich, Mark S Roberts, et al.
Pageof 17